autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-011528
A preparation of autologous T lymphocytes (ATL) that have been transduced with the retroviral vector SFG, a Moloney murine leukemia (Mo-MuLV) virus-based vector, encoding human C-C chemokine receptor 4 (CCR4), linked via an internal ribosome entry site (IRES), to a chimeric antigen receptor (CAR) composed of a single chain single-chain variable fragment (scFv) directed against the CD30 antigen (CAR.CD30) and linked, via the spacer human IgG1 immunoglobulin heavy constant region (hinge-CH2CH3 region), to the co-stimulatory domains of CD28 and the zeta chain of the TCR/CD3 complex (CD3-zeta) (CD28zeta), with potential immunostimulating and antineoplastic activities. Upon administration of the autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T lymphocytes, the expressed CCR4 on the T cells allows for enhanced migration of the cells to chemokine-secreting tumor cells. The expressed CAR.CD30 moiety specifically recognizes and binds to CD30-expressing tumor cells, resulting in specific T-cell-mediated tumor cell lysis. CD30, a cell surface receptor and a member of the tumor necrosis factor (TNF) receptor superfamily, is transiently expressed on activated lymphocytes and is constitutively expressed in hematologic malignancies. CCR4, a G-coupled-protein receptor for C-C chemokines normally expressed on regulatory T cells (Tregs) but not on cytotoxic T lymphocytes (CTLs), is involved in chemokine-mediated cellular migration. The co-expression of CCR4 on these CTLs may enhance their anti-tumor activity compared to T lymphocytes expressing the same CAR-CD30 receptor but without CCR4 expression.
| Identifier | MLC-T-ONC-011528 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ATLCAR.CD30.CCR4 cells; ATLCAR.CD30-CD28zeta-CCR4 cells; SFG.CCR4-CAR.CD30 autologous T lymphocytess; autologous CCR4-CAR-CD19-CD28-zeta-transduced T lymphocytes; anti-CD30-CAR/CD28z-CCR4 retroviral vector-transduced autologous T cells; ATLs co-expressing CD30-CARCD28zeta and CCR4; CCR4-CAR-CD30-28zeta-specific autologous T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011528",
"term": "autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes (ATL) that have been transduced with the retroviral vector SFG, a Moloney murine leukemia (Mo-MuLV) virus-based vector, encoding human C-C chemokine receptor 4 (CCR4), linked via an internal ribosome entry site (IRES), to a chimeric antigen receptor (CAR) composed of a single chain single-chain variable fragment (scFv) directed against the CD30 antigen (CAR.CD30) and linked, via the spacer human IgG1 immunoglobulin heavy constant region (hinge-CH2CH3 region), to the co-stimulatory domains of CD28 and the zeta chain of the TCR/CD3 complex (CD3-zeta) (CD28zeta), with potential immunostimulating and antineoplastic activities. Upon administration of the autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T lymphocytes, the expressed CCR4 on the T cells allows for enhanced migration of the cells to chemokine-secreting tumor cells. The expressed CAR.CD30 moiety specifically recognizes and binds to CD30-expressing tumor cells, resulting in specific T-cell-mediated tumor cell lysis. CD30, a cell surface receptor and a member of the tumor necrosis factor (TNF) receptor superfamily, is transiently expressed on activated lymphocytes and is constitutively expressed in hematologic malignancies. CCR4, a G-coupled-protein receptor for C-C chemokines normally expressed on regulatory T cells (Tregs) but not on cytotoxic T lymphocytes (CTLs), is involved in chemokine-mediated cellular migration. The co-expression of CCR4 on these CTLs may enhance their anti-tumor activity compared to T lymphocytes expressing the same CAR-CD30 receptor but without CCR4 expression.",
"synonyms": [
"ATLCAR.CD30.CCR4 cells",
"ATLCAR.CD30-CD28zeta-CCR4 cells",
"SFG.CCR4-CAR.CD30 autologous T lymphocytess",
"autologous CCR4-CAR-CD19-CD28-zeta-transduced T lymphocytes",
"anti-CD30-CAR/CD28z-CCR4 retroviral vector-transduced autologous T cells",
"ATLs co-expressing CD30-CARCD28zeta and CCR4",
"CCR4-CAR-CD30-28zeta-specific autologous T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-ccr4-cd30car-cd28-cd3zeta-expressing-t-lymphocytes/"
}
Record 2,862 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.